[go: up one dir, main page]

WO1999025817A3 - Tc1-based transposon vectors - Google Patents

Tc1-based transposon vectors Download PDF

Info

Publication number
WO1999025817A3
WO1999025817A3 PCT/US1998/024348 US9824348W WO9925817A3 WO 1999025817 A3 WO1999025817 A3 WO 1999025817A3 US 9824348 W US9824348 W US 9824348W WO 9925817 A3 WO9925817 A3 WO 9925817A3
Authority
WO
WIPO (PCT)
Prior art keywords
transposon vectors
traps
based transposon
vectors
gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US1998/024348
Other languages
French (fr)
Other versions
WO1999025817A2 (en
WO1999025817A9 (en
Inventor
Perry B Hackett
Karl J Clark
Adam J Dupuy
Stephen C Ekker
David A Largaespada
Zoltan Ivics
Zsuzsanna Izsvak
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Minnesota Twin Cities
University of Minnesota System
Original Assignee
University of Minnesota Twin Cities
University of Minnesota System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Minnesota Twin Cities, University of Minnesota System filed Critical University of Minnesota Twin Cities
Priority to EP98957974A priority Critical patent/EP1034258A2/en
Priority to JP2000521183A priority patent/JP2001523450A/en
Priority to CA002309000A priority patent/CA2309000A1/en
Priority to AU14103/99A priority patent/AU1410399A/en
Publication of WO1999025817A2 publication Critical patent/WO1999025817A2/en
Publication of WO1999025817A3 publication Critical patent/WO1999025817A3/en
Publication of WO1999025817A9 publication Critical patent/WO1999025817A9/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/60—Vectors containing traps for, e.g. exons, promoters
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/90—Vectors containing a transposable element
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
    • C12N2830/005—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination repressible enhancer/promoter combination, e.g. KRAB
    • C12N2830/006—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination repressible enhancer/promoter combination, e.g. KRAB tet repressible
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
    • C12N2840/203—Vectors comprising a special translation-regulating system translation of more than one cistron having an IRES
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/44—Vectors comprising a special translation-regulating system being a specific part of the splice mechanism, e.g. donor, acceptor

Landscapes

  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Mycology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The present invention provides for transposon vectors encoding expression control region-traps and gene-traps. Also provided are dicistronic vectors. Certain embodiments of the invention contain internal ribosome entry sites.
PCT/US1998/024348 1997-11-13 1998-11-13 Tc1-based transposon vectors Ceased WO1999025817A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
EP98957974A EP1034258A2 (en) 1997-11-13 1998-11-13 Nucleic acid transfer vector for the introduction of nucleic acid into the dna of a cell
JP2000521183A JP2001523450A (en) 1997-11-13 1998-11-13 Nucleic acid transfer vector for introducing nucleic acid into cell DNA
CA002309000A CA2309000A1 (en) 1997-11-13 1998-11-13 Tc1-based transposon vectors
AU14103/99A AU1410399A (en) 1997-11-13 1998-11-13 Nucleic acid transfer vector for the introduction of nucleic acid into the dna of a cell

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6530397P 1997-11-13 1997-11-13
US60/065,303 1997-11-13

Publications (3)

Publication Number Publication Date
WO1999025817A2 WO1999025817A2 (en) 1999-05-27
WO1999025817A3 true WO1999025817A3 (en) 1999-08-05
WO1999025817A9 WO1999025817A9 (en) 1999-09-10

Family

ID=22061760

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1998/024348 Ceased WO1999025817A2 (en) 1997-11-13 1998-11-13 Tc1-based transposon vectors

Country Status (5)

Country Link
EP (1) EP1034258A2 (en)
JP (1) JP2001523450A (en)
AU (1) AU1410399A (en)
CA (1) CA2309000A1 (en)
WO (1) WO1999025817A2 (en)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE466948T1 (en) 1997-03-11 2010-05-15 Univ Minnesota DNA-BASED TRANSPOSON SYSTEM FOR INTRODUCING NUCLIC ACID INTO A CELL'S DNA
US7160682B2 (en) 1998-11-13 2007-01-09 Regents Of The University Of Minnesota Nucleic acid transfer vector for the introduction of nucleic acid into the DNA of a cell
JP2002543792A (en) * 1999-05-11 2002-12-24 リージェンツ オブ ザ ユニバーシティ オブ ミネソタ Supply and integration of transposon sequences by vector
WO2001029205A2 (en) * 1999-10-19 2001-04-26 Minos Biosystems Limited Method for genetic manipulation
AU1100201A (en) 1999-10-28 2001-05-08 Board Of Trustees Of The Leland Stanford Junior University Methods of in vivo gene transfer using a sleeping beauty transposon system
BR0107930A (en) 2000-01-28 2004-06-15 Scripps Research Inst Methods for identifying synthetic transcriptional and translational regulatory elements, and compositions relating to them
WO2001081565A2 (en) * 2000-04-27 2001-11-01 Max-Delbrück-Centrum für Molekulare Medizin Sleeping beauty, a transposon vector with a broad host range for the genetic transformation in vertebrates
EP1286699A2 (en) * 2000-05-19 2003-03-05 Regents Of The University Of Minnesota Composition for delivery of compounds to cells
WO2003089618A2 (en) 2002-04-22 2003-10-30 Regents Of The University Of Minnesota Transposon system and methods of use
DE10224242A1 (en) * 2002-05-29 2003-12-11 Max Delbrueck Centrum Frog Prince, a transposon vector for vertebrate gene transfer
US7985739B2 (en) 2003-06-04 2011-07-26 The Board Of Trustees Of The Leland Stanford Junior University Enhanced sleeping beauty transposon system and methods for using the same
US7919583B2 (en) 2005-08-08 2011-04-05 Discovery Genomics, Inc. Integration-site directed vector systems
WO2009003671A2 (en) 2007-07-04 2009-01-08 Max-Delbrück-Centrum für Molekulare Medizin Hyperactive variants of the transposase protein of the transposon system sleeping beauty
WO2011153440A2 (en) 2010-06-04 2011-12-08 Regents Of The University Of Minnesota Transposon mutagenesis system and methods of use
RU2688485C2 (en) 2014-01-07 2019-05-21 Фундасио Привада Институт Де Медисина Предиктива И Персоналицада Дель Кансер Methods of obtaining libraries of two-chain dna and methods of sequencing for identifying methylated cytosines
BR112020000406A2 (en) * 2017-07-10 2022-09-13 Inst De Biologia Molecular Do Parana Ibmp GENETIC PLATFORM FOR HETEROLOGOUS OVEREXPRESSION ASSOCIATED WITH THE SELECTION OF HIGHLY PROTEIN PRODUCING CELLS
US20230242654A1 (en) 2017-07-29 2023-08-03 Juno Therapeutics, Inc. Reagents for expanding cells expressing recombinant receptors
BR112020008340A2 (en) 2017-11-01 2020-11-17 Juno Therapeutics Inc process for generating therapeutic compositions of modified cells
JP7258899B2 (en) 2017-11-01 2023-04-17 ジュノー セラピューティクス インコーポレイテッド Methods for making T cell compositions
MX2020005908A (en) 2017-12-08 2020-10-07 Juno Therapeutics Inc Process for producing a composition of engineered t cells.
JP2022554348A (en) 2019-11-05 2022-12-28 ジュノー セラピューティクス インコーポレイテッド Methods of Determining Attributes of Therapeutic T Cell Compositions
WO2021197342A1 (en) * 2020-03-30 2021-10-07 Institute Of Zoology, Chinese Academy Of Sciences Active dna transposon systems and methods for use thereof
US20230178239A1 (en) 2020-05-13 2023-06-08 Juno Therapeutics, Inc. Methods of identifying features associated with clinical response and uses thereof
AU2022241654A1 (en) 2021-03-22 2023-09-28 Juno Therapeutics, Inc. Methods of determining potency of a therapeutic cell composition
US20250051735A1 (en) 2021-12-22 2025-02-13 Vanderbilt University Next generation transpososomes
US20250345432A1 (en) 2022-05-25 2025-11-13 Celgene Corporation Method for predicting response to a t cell therapy
JP2025517371A (en) 2022-05-27 2025-06-05 カイト ファーマ インコーポレイテッド Non-viral delivery of cell therapy constructs
WO2024220588A1 (en) 2023-04-18 2024-10-24 Juno Therapeutics, Inc. Cytotoxicity assay for assessing potency of therapeutic cell compositions
WO2024243365A2 (en) 2023-05-23 2024-11-28 Juno Therapeutics, Inc. Activation markers of t cells and method for assessing t cell activation

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997029202A1 (en) * 1996-02-09 1997-08-14 Het Nederlands Kanker Instituut Vectors and methods for providing cells with additional nucleic acid material integrated in the genome of said cells
WO1998040510A1 (en) * 1997-03-11 1998-09-17 Regents Of The University Of Minnesota Dna-based transposon system for the introduction of nucleic acid into dna of a cell

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997029202A1 (en) * 1996-02-09 1997-08-14 Het Nederlands Kanker Instituut Vectors and methods for providing cells with additional nucleic acid material integrated in the genome of said cells
WO1998040510A1 (en) * 1997-03-11 1998-09-17 Regents Of The University Of Minnesota Dna-based transposon system for the introduction of nucleic acid into dna of a cell

Non-Patent Citations (10)

* Cited by examiner, † Cited by third party
Title
CLARKE N J ET AL: "pPV: a novel IRES-containing vector to facilitate plasmid immunization and antibody response characterization", IMMUNOTECHNOLOGY, vol. 3, no. 2, June 1997 (1997-06-01), pages 145-153, XP004126677 *
GURTU V ET AL: "IRES bicistronic expression vectors for efficient creation of stable mammalian cell lines.", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, (1996 DEC 4) 229 (1) 295-8. JOURNAL CODE: 9Y8. ISSN: 0006-291X., United States, XP002100809 *
IVICS Z ET AL: "IDENTIFICATION OF FUNCTIONAL DOMAINS AND EVOLUTION OF TC1-LIKE TRANSPOSABLE ELEMENTS", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, vol. 93, 14 May 1996 (1996-05-14), pages 5008 - 5013, XP002072767 *
IVICS Z ET AL: "MOLECULAR RECONSTRUCTION OF SLEEPING BEAUTY, A TC1-LIKE TRANSPOSON FROM FISH, AND ITS TRANSPOSITION IN HUMAN CELLS", CELL, vol. 91, no. 4, 14 November 1997 (1997-11-14), pages 501 - 510, XP002072766 *
IZSVAK Z ET AL: "CHARACTERIZATION OF A TC1-LIKE TRANSPOSABLE ELEMENT IN ZEBRAFISH (DANIO RERIO)", MOLECULAR AND GENERAL GENETICS, vol. 247, no. 3, 1995, pages 312 - 322, XP002072765 *
J C VOS ET AL: "Transposase is the only nematode protein required for in vitro transposition of TC1", GENES AND DEVELOPMENT, vol. 10, no. 6, 15 March 1996 (1996-03-15), pages 755-61, XP002088205 *
RADICE, ANTHONY D. ET AL: "Widespread occurrence of the Tc1 transposon family: Tc1-like transposons from teleost fish", MOL. GEN. GENET. (1994), 244(6), 606-12 CODEN: MGGEAE;ISSN: 0026-8925, 1994, XP002100807 *
SCHOUTEN, GOVERT J. ET AL: "Transposon Tc1 of the nematode Caenorhabditis elegans jumps in human cells.", NUCLEIC ACIDS RESEARCH, (JUNE 15, 1998) VOL. 26, NO. 12, PP. 3013-3017. ISSN: 0305-1048., XP002088087 *
SZEKELY A A ET AL: "P element mediated germ line transformation of Drosophila melanogaster with the Tc1 transposable DNA element from Caenorhabditis elegans.", GENOME, (1994 JUN) 37 (3) 356-66. JOURNAL CODE: FNP. ISSN: 0831-2796., Canada, XP002100808 *
URABE M ET AL: "A novel dicistronic AAV vector using a short IRES segment derived from hepatitis C virus genome", GENE: AN INTERNATIONAL JOURNAL ON GENES AND GENOMES, vol. 200, no. 1-2, 24 October 1997 (1997-10-24), pages 157-162, XP004126490 *

Also Published As

Publication number Publication date
AU1410399A (en) 1999-06-07
JP2001523450A (en) 2001-11-27
WO1999025817A2 (en) 1999-05-27
EP1034258A2 (en) 2000-09-13
CA2309000A1 (en) 1999-05-27
WO1999025817A9 (en) 1999-09-10

Similar Documents

Publication Publication Date Title
WO1999025817A3 (en) Tc1-based transposon vectors
WO1996017072A3 (en) Recombinant alphavirus vectors
WO1995007994A3 (en) Recombinant alphavirus vectors
BG103886A (en) Regulation of the expression of quinolate phospho- ribosyltransferase
EP1400523A3 (en) Intermediate compounds
AU5741296A (en) Translumenal circumferential injector
AU6883798A (en) Method of anesthesia
ZA98586B (en) "Hydrogenation of hydrocarbons".
HUP0001650A3 (en) Improved expression vectors
IL128590A0 (en) Insecticidal protein toxins from photorhabdus
AU8333398A (en) Injection member
AU2929595A (en) New internal ribosome entry site, vector containing it and therapeutical use
AU1816699A (en) Internal cmos reference generator and voltage regulator
WO1997030082A3 (en) Antifungic and antibacterial peptide
IL118449A (en) Blended missile autopilot
ZA965922B (en) Preparation of N-substituted 3-hydroxypyrazoles.
AUPO412896A0 (en) Electromagnetic gas injection valve
GB9827280D0 (en) Keypad aid for the partially sighted
PL337757A1 (en) Novel lyposomic vectors of an active ingredient
AU6303898A (en) Component of bromelain
AU3925695A (en) Injection anchor
AU5057898A (en) Novel constructs and vectors for the targeted and inducible expression of genes
ZA9811409B (en) Biodegradation of explosives.
PL341679A1 (en) Benzylidene pyrazolones, method of obtaininbg them and their application
ZA977530B (en) Biodegradation of explosives.

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: C2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: C2

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

COP Corrected version of pamphlet

Free format text: PAGES 1/20-20/20, DRAWINGS, REPLACED BY NEW PAGES 1/20-20/20; DUE TO LATE TRANSMITTAL BY THE RECEIVING OFFICE

ENP Entry into the national phase

Ref document number: 2309000

Country of ref document: CA

Ref country code: CA

Ref document number: 2309000

Kind code of ref document: A

Format of ref document f/p: F

NENP Non-entry into the national phase

Ref country code: KR

ENP Entry into the national phase

Ref country code: JP

Ref document number: 2000 521183

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 1998957974

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 1998957974

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1998957974

Country of ref document: EP